CompaniesAccovion

Accovion

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

0

As Collaborator

5

Total Enrollment

1,160

By Phase

NA: 1PHASE3: 3PHASE4: 1

By Status

COMPLETED: 4TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
NCT01453179
NCT02065882
NCT02144077
NCT02553239
Hover over trial bars to see details

Recent Trials

NCT02553239Collaborator
CoolLoop Paroxysmal Atrial Fibrillation
NATerminated
20 participants
Started: Jul 31, 2014 · Completed: Feb 14, 2019
NCT02144077Collaborator
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
PHASE3Completed
281 participants
Started: Jan 28, 2014 · Completed: Sep 9, 2020
NCT02065882Collaborator
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
PHASE3Completed
67 participants
Started: Mar 31, 2013 · Completed: Nov 18, 2020
NCT01453179Collaborator
Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)
PHASE4Completed
221 participants
Started: Oct 31, 2011 · Completed: Mar 31, 2015
NCT02799069Collaborator
Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy
PHASE3Completed
571 participants
Started: Apr 30, 2008 · Completed: Aug 31, 2009
Related Companies
Clinipace
acquired